French Researchers Developing Key NanoArrayer(TM) Applications

Aug 03, 2006, 01:00 ET from BioForce Nanosciences, Inc.

    AMES, Iowa, Aug. 3 /PRNewswire-FirstCall/ -- BioForce Nanosciences (OTC
 Bulletin Board: BFNH), manufacturer of the NanoArrayer(TM) System for
 enabling new nanotechnology applications, has announced the placement of a
 NanoArrayer in Paris at the Universite Pierre & Marie Curie (UPMC) for
 technology evaluation by CNRS (Centre National de la Recherche
 Scientifique), the French National Center for Scientific Research.
     The NanoArrayer was installed in May in the laboratory of Dr. Fatiha
 Nothias who noted, "Our plan is to use the unique printing capabilities of
 the NanoArrayer to pattern proteins associated with cell morphology
 establishment and migration." Dr Nothias said, "Our end goal is to
 determine the consequences of the interactions of neurons and glial cells
 with these patterned proteins." Other French research groups in the same
 institute have expressed interest in utilizing the NanoArrayer to study how
 cells sense their environment during the organization of the embryonic
     Michael Lynch, Product Manager for the NanoArrayer, assisted with the
 installation and training process. He noted that, "The NanoArrayer enables
 protein patterning in the significantly small dimensions required to study
 single cell growth and development important in Neuroscience, Cancer
 Biology, Stem Cell Research, Genetic Disease and more." Lynch added, "This
 installation also provided an opportunity to introduce NanoAndMore, our
 European distributor for the NanoArrayer product line, to these new and
 exciting markets."
     "This technology agreement partnership with UPMC and CNRS provides
 BioForce with valuable new market applications of the NanoArrayer," noted
 Kerry Frey, BioForce COO. "Our goal is continued growth into emerging new
 bionanotechnology markets in Europe and this placement, our second overseas
 this year, continues our progress."
     About BioForce Nanosciences, Inc.
     BioForce Nanosciences is a nanotechnology tools and applications
 Company, providing innovative and practical products that support the
 growth of the nanotechnology industry. The Company has spent more than a
 decade of invention, research and development on patented and
 patent-pending nanotechnology products. The core technology is the
 NanoArrayer(TM) Benchtop Molecular Printer, a portal to new opportunities
 in nanotechnology. The NanoArrayer opens the door to new and important
 applications in the biomedical and life sciences markets that lead to
 improved quality of life. BioForce continues to target inventions that
 further expand the reach of its proprietary technology and expand its
 robust patent, trademark and IP portfolio.
     BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) company
 brings inventions to the marketplace that complement existing innovations,
 licensing and acquisitions. BioForce is a wholly owned subsidiary of
 BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board:   BFNH.OB). For
 more information, visit or contact BioForce at or 515-233-8333.
     This news release contains forward-looking information that may be
 affected by certain risks and uncertainties, including those risks and
 uncertainties described in the company's most recent filings with the
 Securities and Exchange Commission. The company's actual results could
 differ materially from such forward-looking statements. We assume no duty
 to update these statements at any future date.

SOURCE BioForce Nanosciences, Inc.